
Test-Driving The Polestar3 Electric
Polestar 3 Long range Single motor Polestar
It announces 'electric,' from its minimalist front fascia to its wide, low stance and body-colored Pollstar badge. Its flush side profile gives it gravitas. It's a big guy, and the large panoramic moonroof lends it a romantic flavor - you can park and look up at the stars. My neighbors have seen many a ride in my driveway but this one evoked immediate, positive comments.
2025 Polestar3 Polestar
Inside, the vehicle is reminiscent of Tesla in that 'You sit down and the vehicle is on.' It offers a similarly minimalist cabin with high-quality, sustainable materials. Upholstery options include Nappa leather, wool, and vegan alternatives like MicroTech. It seats five, with heated and ventilated front seats and heated rear seats. Cargo space is 17.1 cubic feet behind the rear seats, with a small frunk for additional storage. It's nice and big inside, as an SUV should be.
2025 Polestar3 Polestar
You've got a 14.5-inch central touchscreen, a 9-inch digital driver display and an optional head-up display for essential driving information. Standard features include wireless Apple CarPlay, Android Auto, Bluetooth, and multiple USB-C ports. An optional 25-speaker Bowers & Wilkins audio system is rich and deep and crispy and therefore good.
2025 Polestar3 Polestar
All models feature a 111-kWh battery pack, with DC fast charging capabilities allowing a 10-80% charge in approximately 30 minutes. I had the top-end Performance Pack, delivering 517 hp, 671 lb-ft torque, 0-60 mph in 4.7 seconds, and a pretty-good EPA-estimated range of 279 miles. Charging was a simple, routine matter. Driving Experience
As you expect with a vehicle with this much blast power, acceleration is hasty and satisfying. You'll have to remember you are driving a vehicle weighing upwards of 5,550 pounds because it feels light as the proverbial feather. It's composed around corners and regenerative braking allows for one-pedal driving. Brakes are tight-tight. Visibility is satisfactory. It is a smooth, satisfying drive.
Polestar 3 Long range Single motor Polestar Pricing
My Dual motor trip starts at $84,900. With all options and extras, it tops out at $93,100. Available packages include the Plus Pack (soft-close doors, heated steering wheel, upgraded audio), Pilot Pack (advanced driver assistance systems, head-up display), and Performance Pack (enhanced power, sport-tuned suspension, 22-inch wheels) Room for improvement
On my first voyage, I emerged from a store and found myself locked out for about 10 minutes. I thought it was time for the tow truck, maybe. But then, out of the blue, the vehicle relented. It never got itself together with that fob, though - sometimes it worked, sometimes it didn't, up until the last 20 minutes I had the vehicle. Also, the tech is complicated and of course learnable, but to open the glove box positioned below the passenger seat, for example, required three separate steps on the touch screen. Safety Features
Standard safety features include automatic emergency braking, lane-keeping assist, blind-spot monitoring, adaptive cruise control, and a driver attention monitor. An optional LiDAR system enhances semi-autonomous driving capabilities,
Conclusion: It is a fine start from a fine brand and as soon as the electronics work 100% of the time, it'll be sweet indeed.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

E&E News
4 minutes ago
- E&E News
Joint EU-US statement confirms lower tariffs on autos, other sectors
The United States and the EU on Thursday executed the verbal agreement President Donald Trump and European Commission President Ursula von der Leyen reached in Scotland late last month, including lowering tariffs on automobiles and other sectors to 15 percent. The White House framed the statement as an important step toward reaching a comprehensive deal with the 27-nation bloc, collectively the United States' largest trading partner. 'These are ambitious things and we expect in the coming weeks … to fully paper over the agreement,' a senior administration official told reporters Wednesday evening ahead of the announcement. Advertisement The joint statement affirms several aspects of the verbal agreement the president unveiled July 27, including a 15 percent tariff rate on most goods — half the 30 percent rate Trump had threatened. That includes critical sectors like autos, following weeks of uncertainty that had frustrated the EU.


Associated Press
34 minutes ago
- Associated Press
Dr. Nikola Cihoric Redefines Clinical Research Through Innovation, Technology, and Data
ZURICH, SWITZERLAND, August 21, 2025 / / -- Bridging Medicine, Research, and Technology for Patient-Centric Solutions Dr. Nikola Cihoric, founder and visionary behind Wemedoo AG, is redefining clinical research by merging technology, innovation, medicine, and data into a seamless ecosystem that empowers healthcare professionals and researchers alike. With over 15 years of experience in radiation oncology and a deep commitment to clinical data standardization, Dr. Cihoric is setting a new standard in the way clinical trials are conducted worldwide. A Vision Born from Real Clinical Challenges Wemedoo was born from Dr. Cihoric's firsthand frustration with fragmented healthcare systems and inefficient clinical workflows. 'I observed the paper world and sloppy digitalization that slowed treatment delivery and overburdened medical staff,' he explains. His focus on data standardization and cross-sector collaboration led to the development of an early prototype, oopus (initially SmartOncology), which received support from the Swiss Cancer Foundation. Building on this experience, Wemedoo developed its unique approach, which eliminates silos, enhances transparency, and gives researchers full control across the clinical data lifecycle. Learn more about Dr. Cihoric's vision in the Xraised interview. Transforming Clinical Trials Through Technology Unlike traditional clinical trial solutions that rely on multiple disconnected systems, Wemedoo's oomnia system integrates EDC, CTMS, eTMF, eConsent, RTSM, and advanced reporting in a single, unified, and interoperable environment. This approach eliminates costly integrations, reduces errors, and ensures data consistency across every stage of a trial. 'By using technology to unify processes, we save time, reduce errors, and provide real-time insights for clinicians and researchers,' Dr. Cihoric notes. 'Our no-code configuration also allows rapid adaptation to evolving trial requirements, ensuring flexibility without compromising quality.' Ethical AI and Data-Driven Innovation Wemedoo integrates AI into oomnia practically and responsibly, focusing on automating processes where it delivers immediate value without unnecessary risks, essential in a highly regulated industry. Their work is guided by explainability and transparency, from AI-driven risk assessment tools for protocol design to semantic mapping engines that cut data processing timelines from months to days. Wemedoo is also exploring agentic AI to support operational decision-making, always with a 'man-in-control' philosophy to ensure accountability. What makes this possible is oomnia's semantic foundation, structured data, common data elements, and standard vocabularies, which keep outcomes reproducible, interpretable, and aligned with regulatory frameworks. Beyond technology, Wemedoo collaborates with public institutions and publish in peer-reviewed journals, reinforcing their belief that AI is only meaningful if it strengthens trust, transparency, and data integrity. Balancing Clinical Practice and Product Development Despite his active role at Wemedoo, Dr. Cihoric continues to work in a leading academic hospital. This dual role allows him to translate real-world clinical challenges into actionable system improvements. 'Being close to patients and clinical teams keeps me grounded in reality, ensuring that our technology delivers tangible benefits,' he says. Long-Term Vision for Clinical Research Looking ahead, Dr. Cihoric aims to remove barriers between clinical practice and research, investing in education, resources, and stakeholder alignment to ultimately improve patient outcomes. 'The goal is to create a future where innovation, technology, and real-world data converge seamlessly to benefit patients worldwide,' he asserts. About Dr. Nikola Cihoric Dr. Nikola Cihoric is a radiation oncologist, researcher, and founder of Wemedoo AG, with expertise in clinical data standardization, AI integration, and oncology innovation. He has published over 35 scientific papers and actively contributed to international standards groups such as mCODE, CodeX, HL7/FHIR, and CDISC. For more information on Dr. Nikola Cihoric and Wemedoo's groundbreaking work, visit Wemedoo and explore insights from Xraised ( ). Media and Business Inquiries General contact: [email protected] Business development: [email protected] Website: LinkedIn: Wemedoo AG. Gianmarco Giordaniello Xraised email us here Visit us on social media: LinkedIn Instagram X Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Bloomberg
34 minutes ago
- Bloomberg
US and EU Take Steps to Formalize Trade Deal
Details of a trade pact between the US and EU have been released, with a joint statement issued today saying that tariffs on European cars could be cut within weeks, with the potential for reductions on other goods, too. After a preliminary deal announced a month ago, the statement lists specific benchmarks for the EU to get sector-specific discounts on cars, drugs and semiconductors. It also details new commitments to cooperate on standards for food, as well as economic security and digital trade.